Management of Uncontrolled Hypertension on Losartan and Hydrochlorothiazide

Current Medication Assessment

• The patient is currently on losartan (an ARB) and hydrochlorothiazide (a thiazide diuretic) but blood pressure remains uncontrolled 1
• This combination provides two of the three first-line antihypertensive drug classes recommended by current guidelines 1, 2
• According to treatment algorithms, when blood pressure remains uncontrolled on an ARB plus thiazide diuretic, the next step is to add a calcium channel blocker 1, 2, 3

Step-by-Step Management Approach

• Add a dihydropyridine calcium channel blocker (DHP-CCB) such as amlodipine 5-10mg daily 1, 2, 3
• This three-drug combination (ARB + thiazide diuretic + DHP-CCB) represents the optimal triple therapy according to the International Society of Hypertension guidelines 1, 2
• The combination provides complementary mechanisms of action for blood pressure control 3

Next Steps in Therapy

• If blood pressure remains uncontrolled after triple therapy, add spironolactone 25-50mg daily as the fourth agent 1, 2, 3
• If spironolactone is not tolerated or contraindicated, alternatives include amiloride, doxazosin, eplerenone, clonidine, or a beta-blocker 1, 2

Target Blood Pressure Goals

• Aim for blood pressure <130/80 mmHg 1, 3
• Target reduction should be at least 20/10 mmHg from baseline 1, 2
• Blood pressure control should be achieved within 3 months 1, 2

Important Considerations and Caveats

• Avoid non-dihydropyridine calcium channel blockers (diltiazem, verapamil) if the patient has heart failure due to negative inotropic effects 4
• Alpha-blockers like doxazosin should be used only if other agents are inadequate for blood pressure control 4
• Consider single-pill combinations to improve adherence when possible 1, 2
• If blood pressure remains uncontrolled despite optimal four-drug therapy, refer to a specialist with expertise in resistant hypertension 1, 2

Management of Uncontrolled Hypertension

Monitoring and Dose Adjustments

• The American Heart Association recommends evaluating blood pressure response within 2-4 weeks of medication changes 5
• The American Heart Association suggests targeting blood pressure should be <130/80 mmHg for most patients 6
• Monitoring for electrolyte abnormalities, particularly potassium and sodium, is necessary after adding the thiazide diuretic, as recommended by the American Heart Association 6

Special Considerations

• For patients with concomitant coronary artery disease, the American Heart Association recommends considering adding a beta-blocker 6
• The American Heart Association advises being cautious about fluid retention when using calcium channel blockers, which can be counteracted by concurrent diuretic therapy 6